<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>315002</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>1331239</PubmedId>
            <Abstract>Previous studies have indicated that most HLA-A2-binding peptides are 9 amino acid (aa) residues long, with a Leu at position 2 (P2), and a Val or Leu at P9. We compared the binding properties of different peptides by measuring the rate of dissociation of beta 2-microglobulin from peptide-specific HLA-A2 complexes. The simplest peptide that we identified that could form HLA-A2 complexes had the sequence (in single letter aa code) GLFGGGGGV, indicating that three nonglycine aa are sufficient for binding to HLA-A2. To determine whether most nonapeptides that contained Leu at P2 and Val or Leu at P9 could bind to HLA-A2, we tested the binding of nonapeptides selected from published HIV and melanoma protein sequences, and found that six of seven tested formed stable HLA-A2 complexes. We identified an optimal antigenic undecapeptide from the cytomegalovirus gB protein that could form stable HLA-A2 complexes that contained apparent anchor residues at P2 and P11 (sequence FIAGN-SAYEYV), indicating that the spacing between anchor residues can be somewhat variable. Finally, we tested the importance of every aa in the influenza A matrix peptide 58-66 (sequence GILGFVFTL) for binding to HLA-A2, by using Ala-substituted and Lys-substituted peptides. We found that multiple positions were important for stable binding, including P2, P3, P5-P7, and P9. We conclude that the P2 and P9 anchor residues are of prime importance for peptide binding to HLA-A2. However, other peptide side chains (especially at P3) contribute to the stability of the interaction. In certain cases, the optimal length for peptide binding can be longer than 9 residues.</Abstract>
            <ArticleYear>1992</ArticleYear>
            <ArticlePages>3580-7</ArticlePages>
            <ArticleTitle>Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Parker</LastName>
                    <ForeName>K C</ForeName>
                </Author>
                <Author>
                    <LastName>Bednarek</LastName>
                    <ForeName>M A</ForeName>
                </Author>
                <Author>
                    <LastName>Hull</LastName>
                    <ForeName>L K</ForeName>
                </Author>
                <Author>
                    <LastName>Utz</LastName>
                    <ForeName>U</ForeName>
                </Author>
                <Author>
                    <LastName>Cunningham</LastName>
                    <ForeName>B</ForeName>
                </Author>
                <Author>
                    <LastName>Zweerink</LastName>
                    <ForeName>H J</ForeName>
                </Author>
                <Author>
                    <LastName>Biddison</LastName>
                    <ForeName>W E</ForeName>
                </Author>
                <Author>
                    <LastName>Coligan</LastName>
                    <ForeName>J E</ForeName>
                </Author>
            </Authors>
            <Affiliations>Biological Resources Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.</Affiliations>
            <ArticleChemicalList>Antigens, Viral;HIV Antigens;HLA-A2 Antigen;Peptides;Viral Matrix Proteins;Glycine</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Antigens, Viral(chemistry; immunology); Cytomegalovirus(immunology); Glycine(chemistry); HIV Antigens(immunology); HIV-1(immunology); HLA-A2 Antigen(metabolism); Humans; In Vitro Techniques; Influenza A virus(immunology); Molecular Sequence Data; Peptides(chemistry; metabolism); Structure-Activity Relationship; Viral Matrix Proteins(chemistry; immunology)</ArticleMeshHeadingsList>
            <Comments>Data originally imported from the Database of Functional Molecular Immunology, FIMM (http://sdmc.lit.org.sg:8080/fimm/) and from the HLA Ligand Database (http://hlaligand.ouhsc.edu/)</Comments>
            <Journal>
                <Volume>149</Volume>
                <Issue>11</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HIV gag 77-85</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SLYNTVATL</LinearSequence>
                        <StartingPosition>77</StartingPosition>
                        <EndingPosition>85</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04591.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11706</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>59613</EpitopeId>
                <ReferenceStartingPosition>77</ReferenceStartingPosition>
                <ReferenceEndingPosition>85</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The identifier of the peptide in the original FIMM database is P001185.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>315008</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Data originally imported from the Database of Functional Molecular Immunology, FIMM (http://sdmc.lit.org.sg:8080/fimm/) and from the HLA Ligand Database (http://hlaligand.ouhsc.edu/).  Recurated by IEDB staff.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HIV gag 151-159</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TLNAWVKVV</LinearSequence>
                        <StartingPosition>151</StartingPosition>
                        <EndingPosition>159</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04591.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11706</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>64961</EpitopeId>
                <ReferenceStartingPosition>151</ReferenceStartingPosition>
                <ReferenceEndingPosition>159</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The identifier of the peptide in the original FIMM database is P001186.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1007027</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HIV pol 968-976</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LLWKGEGAV</LinearSequence>
                        <StartingPosition>1388</StartingPosition>
                        <EndingPosition>1396</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04585.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11706</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>37945</EpitopeId>
                <ReferenceStartingPosition>968</ReferenceStartingPosition>
                <ReferenceEndingPosition>976</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The identifier of the peptide in the original FIMM database is P001193.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1007032</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GLGGGGGGV</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20881</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1006999</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GLGGGGGGL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20880</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1007000</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GIGGGGGGL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20277</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1007002</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GLGFGGGGG</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20878</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1007024</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GGGFGGGGV</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>19740</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1007038</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GLFGGGGGV</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20847</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1007039</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GIFGGGGGV</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20254</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1007040</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GIFGGGGGA</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20253</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1007041</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GIGFGGGGL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20272</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1007042</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GIGGFGGGL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20273</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1007043</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GIGGGFGGL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20274</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1007044</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GIGGGGFGL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20275</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1007045</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GIGGGGGFL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20276</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1007046</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HIV env 747-755</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RLVNGSLAL</LinearSequence>
                        <StartingPosition>752</StartingPosition>
                        <EndingPosition>760</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03377.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11686</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>54809</EpitopeId>
                <ReferenceStartingPosition>747</ReferenceStartingPosition>
                <ReferenceEndingPosition>755</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1007050</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Data originally imported from the Database of Functional Molecular Immunology, FIMM (http://sdmc.lit.org.sg:8080/fimm/) and from the HLA Ligand Database (http://hlaligand.ouhsc.edu/).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HIV gag 74-82</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ELRSLYNTV</LinearSequence>
                        <StartingPosition>74</StartingPosition>
                        <EndingPosition>82</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04591.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11706</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>13262</EpitopeId>
                <ReferenceStartingPosition>74</ReferenceStartingPosition>
                <ReferenceEndingPosition>82</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1007060</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HIV pol 510-518</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ILKEPVHGV</LinearSequence>
                        <StartingPosition>896</StartingPosition>
                        <EndingPosition>904</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04585.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11706</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>27125</EpitopeId>
                <ReferenceStartingPosition>510</ReferenceStartingPosition>
                <ReferenceEndingPosition>518</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1007067</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>MZ2-E 93-101</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ILESLFRAV</LinearSequence>
                        <StartingPosition>93</StartingPosition>
                        <EndingPosition>101</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P43355.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>27027</EpitopeId>
                <ReferenceStartingPosition>93</ReferenceStartingPosition>
                <ReferenceEndingPosition>101</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1007069</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GILGFVFTL</LinearSequence>
                        <StartingPosition>58</StartingPosition>
                        <EndingPosition>66</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>20354</EpitopeId>
                <ReferenceStartingPosition>58</ReferenceStartingPosition>
                <ReferenceEndingPosition>66</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV and figure 3</LocationOfData>
                        <MhcBindingId>1007070</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The assay measured the relative binding of peptide (20 ÂµM final concentration) to HLA-A2.  Alanine substitution at any position in the MI 58-66peptide does not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 I2L</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GLLGFVFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>20992</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This peptide is an analog of a peptide from the  Influenza A virus with amino acid 59 substitued with leucine.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>1007072</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 12</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FIAGNSAYEYV</LinearSequence>
                        <StartingPosition>619</StartingPosition>
                        <EndingPosition>629</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABQ23592.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>16158</EpitopeId>
                <ReferenceStartingPosition>618</ReferenceStartingPosition>
                <ReferenceEndingPosition>628</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table III</LocationOfData>
                        <TCellId>1008482</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10359</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Cytomegalovirus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>FIAGNSAYEYV</LinearSequence>
                                            <StartingPosition>619</StartingPosition>
                                            <EndingPosition>629</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>ABQ23592.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10359</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>An epitope specific CTL line generated from seropositive individuals and previously described was used in this assay.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>CMV 12</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FIAGNSAYEYV</LinearSequence>
                                        <StartingPosition>619</StartingPosition>
                                        <EndingPosition>629</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>ABQ23592.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10359</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1007087</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PSLKIFIAGNSAYEYV</LinearSequence>
                        <StartingPosition>614</StartingPosition>
                        <EndingPosition>629</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABQ23592.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>49428</EpitopeId>
                <ReferenceStartingPosition>613</ReferenceStartingPosition>
                <ReferenceEndingPosition>628</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1008460</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AGNSAYEYV</LinearSequence>
                        <StartingPosition>621</StartingPosition>
                        <EndingPosition>629</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA45928.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>1627</EpitopeId>
                <ReferenceStartingPosition>620</ReferenceStartingPosition>
                <ReferenceEndingPosition>628</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1008467</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IAGNSAYEY</LinearSequence>
                        <StartingPosition>620</StartingPosition>
                        <EndingPosition>628</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABQ23592.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>25297</EpitopeId>
                <ReferenceStartingPosition>619</ReferenceStartingPosition>
                <ReferenceEndingPosition>627</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1008468</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 4</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FIAGNSAYE</LinearSequence>
                        <StartingPosition>619</StartingPosition>
                        <EndingPosition>627</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABQ23592.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>16157</EpitopeId>
                <ReferenceStartingPosition>618</ReferenceStartingPosition>
                <ReferenceEndingPosition>626</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1008469</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 5</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IFIAGNSAY</LinearSequence>
                        <StartingPosition>618</StartingPosition>
                        <EndingPosition>626</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABQ23592.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>26080</EpitopeId>
                <ReferenceStartingPosition>617</ReferenceStartingPosition>
                <ReferenceEndingPosition>625</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1008470</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 6</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KIFIAGNSA</LinearSequence>
                        <StartingPosition>617</StartingPosition>
                        <EndingPosition>625</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA45928.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>31237</EpitopeId>
                <ReferenceStartingPosition>616</ReferenceStartingPosition>
                <ReferenceEndingPosition>624</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1008471</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 7</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LKIFIAGNS</LinearSequence>
                        <StartingPosition>616</StartingPosition>
                        <EndingPosition>624</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABQ23592.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>36887</EpitopeId>
                <ReferenceStartingPosition>615</ReferenceStartingPosition>
                <ReferenceEndingPosition>623</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1008472</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 8</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SLKIFIAGN</LinearSequence>
                        <StartingPosition>615</StartingPosition>
                        <EndingPosition>623</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABQ23592.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>59215</EpitopeId>
                <ReferenceStartingPosition>614</ReferenceStartingPosition>
                <ReferenceEndingPosition>622</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1008474</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 9</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PSLKIFIAG</LinearSequence>
                        <StartingPosition>614</StartingPosition>
                        <EndingPosition>622</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABQ23592.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>49425</EpitopeId>
                <ReferenceStartingPosition>613</ReferenceStartingPosition>
                <ReferenceEndingPosition>621</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1008475</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 10</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PSLKIFIAGNS</LinearSequence>
                        <StartingPosition>614</StartingPosition>
                        <EndingPosition>624</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABQ23592.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>49426</EpitopeId>
                <ReferenceStartingPosition>613</ReferenceStartingPosition>
                <ReferenceEndingPosition>623</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1008476</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 11</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PSLKIFIAGNSAYE</LinearSequence>
                        <StartingPosition>614</StartingPosition>
                        <EndingPosition>627</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABQ23592.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>49427</EpitopeId>
                <ReferenceStartingPosition>613</ReferenceStartingPosition>
                <ReferenceEndingPosition>626</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1008479</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>CMV 13</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IAGNSAYEYV</LinearSequence>
                        <StartingPosition>620</StartingPosition>
                        <EndingPosition>629</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA45928.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table III</LocationOfData>
                <EpitopeId>25298</EpitopeId>
                <ReferenceStartingPosition>619</ReferenceStartingPosition>
                <ReferenceEndingPosition>628</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table III</LocationOfData>
                        <MhcBindingId>1008483</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Weak reactivity: the peptide was able to sensitize target cells for at least 20% specific lysis at a 2.5:1 E:T ratio at a final concentration of 50-1100 nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M158-64</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GILGFVF</LinearSequence>
                        <StartingPosition>58</StartingPosition>
                        <EndingPosition>64</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>20336</EpitopeId>
                <ReferenceStartingPosition>58</ReferenceStartingPosition>
                <ReferenceEndingPosition>64</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>1008485</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-65</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GILGFVFT</LinearSequence>
                        <StartingPosition>58</StartingPosition>
                        <EndingPosition>65</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>20341</EpitopeId>
                <ReferenceStartingPosition>58</ReferenceStartingPosition>
                <ReferenceEndingPosition>65</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>1008486</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-67</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GILGFVFTLT</LinearSequence>
                        <StartingPosition>58</StartingPosition>
                        <EndingPosition>67</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>20355</EpitopeId>
                <ReferenceStartingPosition>58</ReferenceStartingPosition>
                <ReferenceEndingPosition>67</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>1008487</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-68</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GILGFVFTLTV</LinearSequence>
                        <StartingPosition>58</StartingPosition>
                        <EndingPosition>68</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>20356</EpitopeId>
                <ReferenceStartingPosition>58</ReferenceStartingPosition>
                <ReferenceEndingPosition>68</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>1008488</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 59-67</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ILGFVFTLT</LinearSequence>
                        <StartingPosition>59</StartingPosition>
                        <EndingPosition>67</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>27065</EpitopeId>
                <ReferenceStartingPosition>59</ReferenceStartingPosition>
                <ReferenceEndingPosition>67</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>1008489</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 57-65</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KGILGFVFT</LinearSequence>
                        <StartingPosition>57</StartingPosition>
                        <EndingPosition>65</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>30967</EpitopeId>
                <ReferenceStartingPosition>57</ReferenceStartingPosition>
                <ReferenceEndingPosition>65</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>1008490</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M158-64</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GILGFVF</LinearSequence>
                        <StartingPosition>58</StartingPosition>
                        <EndingPosition>64</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>20336</EpitopeId>
                <ReferenceStartingPosition>58</ReferenceStartingPosition>
                <ReferenceEndingPosition>64</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>1008491</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 60-68</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LGFVFTLTV</LinearSequence>
                        <StartingPosition>60</StartingPosition>
                        <EndingPosition>68</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>36109</EpitopeId>
                <ReferenceStartingPosition>60</ReferenceStartingPosition>
                <ReferenceEndingPosition>68</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>1008492</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 57-68</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KGILGFVFTLTV</LinearSequence>
                        <StartingPosition>57</StartingPosition>
                        <EndingPosition>68</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>30968</EpitopeId>
                <ReferenceStartingPosition>57</ReferenceStartingPosition>
                <ReferenceEndingPosition>68</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>1008493</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>235</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 G1A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AILGFVFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>1991</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008495</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Alanine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 I2A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GALGFVFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>18661</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008496</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Alanine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 L3A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GIAGFVFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20212</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008497</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Alanine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.  Weak reactivity: the peptide was able to sensitize target cells for at least 20% specific lysis at a 2.5:1 E:T ratio at a final concentration of 50-1100 nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 G4A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILAFVFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20326</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008501</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Alanine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 F5A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGAVFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20332</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008502</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Alanine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 V6A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGFAFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20333</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008503</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Alanine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 F7A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGFVATL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20335</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008504</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Alanine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 T8A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGFVFAL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20337</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008505</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Alanine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 L9A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGFVFTA</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20342</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008507</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Alanine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.  Weak reactivity: the peptide was able to sensitize target cells for at least 20% specific lysis at a 2.5:1 E:T ratio at a final concentration of 50-1100 nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 L9K</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGFVFTK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20343</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008508</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Lysine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 T8K</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGFVFKL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20338</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008509</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Lysine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 F7K</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGFVKTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20357</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008510</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Lysine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 V6K</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGFKFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20334</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008511</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Lysine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 F5K</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGKVFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20359</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008512</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Lysine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 G4K</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILKFVFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20363</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008513</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Lysine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 L3K</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GIKGFVFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20315</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008514</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Lysine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 I2K</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GKLGFVFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>20614</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008515</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Lysine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 58-66 G1K</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KILGFVFTL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table V, figure 3</LocationOfData>
                <EpitopeId>31321</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table V and figure 3</LocationOfData>
                        <MhcBindingId>1008516</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Lysine substitution at any position in the wild type influenza MI 58-66 peptide did not abolish binding to HLA-A2.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

